Cruzipain and TGF-β Activation Data for Chagas Disease Research

2020 data from an in vitro study investigates the role of the parasite enzyme cruzipain in activating latent host TGF-β during Trypanosoma cruzi invasion. The dataset supports findings on parasite infectivity, inhibition by Z-Phe-Ala-FMK and chagasin, and links to Chagas disease development. It was authored by Patrícia Mello Ferrão and published under a CC0 license.

Use Cases

• Analyze the correlation between cruzipain activity levels and TGF-β activation metrics to model parasite infectivity.
• Compare T. cruzi invasion rates under experimental conditions with Z-Phe-Ala-FMK inhibitor versus anti-TGF-β neutralizing antibody treatments.
• Model the inhibitory effect of chagasin overexpression on latent TGF-β activation as a potential chemotherapeutic pathway.
• Assess the enhancement of trypomastigote invasive activity following addition of purified cruzipain across experimental replicates.

Strengths

• Data is directly tied to a 2020 peer-reviewed study on a specific mechanism in Chagas disease pathogenesis.
• Experimental design includes multiple validation methods: live parasites, lysates, purified enzyme, and genetic inhibition.
• Published under a permissive CC0 license, enabling unrestricted reuse and analysis.

Limitations

• Dataset scope is confined to in vitro experiments on Vero cell cultures, limiting direct in vivo or clinical applicability.
• Specific quantitative metrics, sample sizes (rows), and measured variables (columns) are not detailed in the provided metadata.

Provenance

Source

Dryad digital repository.

Collection Method

In vitro laboratory assays measuring TGF-β activation, parasite invasion, and growth inhibition.

Time Range

Experimental data circa 2020.

Freshness

Last updated in June 2020.